Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb

Table 6

Main product based on Novasorb technology marketed or to be marketed.

Product	Active ingredient	Indication	Status
Cationorm	Medical device	Dry eye	Marketed
Cyclokat	0.1% cyclosporine A	Severe dry eye	Phase III
Vekacia	0.1% cyclosporine A	Vernal; keratoconjunctivitis	Phase III
Catioprost	0.005% latanoprost	Glaucoma associated with ocular surface disease	Phase II